Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis
Status:
RECRUITING
Trial end date:
2027-12-30
Target enrollment:
Participant gender:
Summary
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset systemic sclerosis
Phase:
PHASE1
Details
Lead Sponsor:
The Children's Hospital of Zhejiang University School of Medicine